Alvotech’s Denosumab Biosimilar Takes Steps Forward With EMA Filing Acceptance
Regulatory Submissions For AVT03 In Other Major Global Markets Are Expected ‘Soon’
Alvotech is the latest to join several other competitors who have already submitted their denosumab biosimilar marketing authorization applications to the EMA.
